Marchesini presents good results for 2014: With turnovers growing by 11 %, the firm eyes new investments in R&S.
Pianoro, Bologna - Despite the rather unstable economic context, the results of Marchesini rose from 222 million in 2013 to 247 million, hence an 11% increase. The growth in turnover recorded during a year that was not exactly a flourishing one for the Italian economy (whose GDP was still showing a negative figure of -0,4 %), is also due to the trend of the Italian pharmaceutical market: figures of 2014 by Italy’s Office for National Statistics and the Bank of Italy have highlighted that pharmaceutical enterprises are in the top position in terms of competitiveness, productivity, R&S intensity and exports. In 2013, Italian exports grew by 14 % and by 64 % over the last five years as opposed to the +7 % of the manufacturing average and the +29 % of the pharmaceutical average within the European Union.
The Group’s growth in turnover matches its performance in gathering orders, with a rise to 217 million compared with the 189 million of two years ago (+15 %). The rise in the number of customer orders is thanks above all to the increased demand for aseptic packaging machinery for anti-cancer drugs, which is one of the fastest growing sectors of recent years (900 million was the turnover of 2011, 1.5 billion is that expected for 2018 according to survey carried out by MarketsandMarkets), thanks to contracts received especially from Russia, Eastern countries and China.
Further Investment in Siena
Now, Marchesini plans further ongoing investments in R&S in its Corima branch in Tuscany, specialising in the design and construction of automatic packaging machines for aseptic pharmaceuticals used especially to treat cancer. A Corima factory in Monteriggioni (Siena) will be expanded from 6,000 to 10,000 square meters, following an investment of 3.5 million Euro. This step will provide workplaces for another 50 employees in addition to the 100 people presently working there, the company stated.
In the meantime, building work continues in Carpi where the Group’s production division of machines for blister packaging and deep-draw thermoforming is located. This project will create the biggest thermoforming centre in Italy, covering 12 thousand square meters thanks to an investment worth 15 million Euro.
Focussing on New Markets
The CEO of the Marchesini Group and Chairman of the Italian Industrial Federation of Emilia-Romagna, Maurizio Marchesini commented: “We are delighted with these results because our expectations of growth for 2014 were exact and also because the future looks thriving. A business leader could be halted by fear in a critical historical time, as is the present one, but the best way out is to explore new markets and to invest in people, in their personal and professional growth. These are the challenges we want to be ready for.”